Healthcare -
Biotechnology - NASDAQ - US
$ 0.4
-42.8 %
$ 145 M
Market Cap
-0.54
P/E
LXRX - STOCK-BASED COMPENSATION
Stock-based Compensation LXRX - Lexicon Pharmaceuticals, Inc.
14.3 M
LAST VALUE
16.44%
2 YEAR CAGR
4.16%
5 YEAR CAGR
6.81%
10 YEAR CAGR